According to N.News on September 6th, the South Korean Food and Drug Safety Ministry has decided to launch an on-site investigation after finding a substance similar to nicotine in nicotine-free e-cigarette liquid.
The organization stated today (6th) that some liquid inhalation products, including nicotine-like substances, are being marketed online under the guise of being "nicotine-free" products. Nicotine-like substances are chemicals with structures similar to nicotine, with methyl nicotine being a representative example.
The organization issued a warning stating that
Due to the lack of verified safety, it is advised not to inhale these products.
Currently, in products similar to cigarettes that are inhaled, those without nicotine and used to improve smoking habits are designated as over-the-counter drugs. As of now, the only nicotine-free product approved by the South Korean Ministry of Food and Drug Safety is "End Puff" domestically.
Prior to this, KBS reported in June on products containing substances similar to nicotine. These products do not fall under the category of non-prescription nicotine products and do not comply with the Tobacco Business Act, and are being sold online.
The South Korean Ministry of Food and Drug Safety stated,
From January to August of this year, we have inspected online products that falsely or exaggeratingly promote themselves as aids to quitting smoking, and have blocked a total of 448 posts. We will continue to inspect advertisements or labels that may be mistaken for non-prescription drugs.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
